What others are saying
- No events
BioView Ltd. (Israeli Publicly trade company) developed a novel non-invasive test to detect genetic changes in bronchial epithelial cells using sputum sample from subjects with pulmonary nodules to aid in the identification of subjects with Lung Cancer. Based on: Duet system and the combined analysis “Target FISH”, combination of morphology and FISH of PRE-SELECTED bronchial epithelial cells population.
BioView’s VP Business Development will be in Australia between the 11th to the 19th of August and is planning to meet with potential business partners, distributors and local pathology labs in order to introduce their company, present you with their revolutionary technology and explore potential collaboration.
If you are interested to hear more in regards to this opportunity and to setup a meeting Contact Us.
IBD Consulting provides complete business development services for leading-edge companies wishing to enter new and emerging markets. From initial consultation and market appraisals, to establishing your solution in your target market, we can assist your company in achieving its international business development goals. At IBD Consulting we choose to work with companies using innovative technologies in the medical, agri and hi-tech sectors, with a focus on companies coming from and seeking entry into the Israeli, Australian and New Zealand markets.